Detalle de: GlyCanDrug: A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer
| Title | GlyCanDrug: A training network on the design of precision therapeutics that target key glycan motifs implicated in cancer |
| Description |
PI: Jesús Angulo. |
| Type Of Funding | HORIZON-TMA-MSCA-DN |
| Funding Agency | European Commission, HORIZON-MSCA-2022-DN-01 |
| Grant Number | 101119601 |
| Project Acronym | GlyCanDrug |
| Period | 2023-2027 |
| Funding Amount | 251,971 € |
| Ontology | |
| Research Groups | Biomolecular Interactions & Structural Glycobiology Lab |
| Researchers |